Kontour (Xi'an) Medical Technology Co., Ltd. (SHA:688314)
China · Delayed Price · Currency is CNY 33.58
-0.42 (-1.24%)
Aug 14, 2026, 3:00 PM CST
SHA:688314 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,728 | 2,686 | 2,340 | 2,674 | 2,784 | 3,829 | |
Market Cap Growth | -18.00% | 14.79% | -12.49% | -3.95% | -27.30% | - |
Enterprise Value | 2,461 | 2,364 | 2,002 | 2,350 | 2,481 | 3,552 |
Last Close Price | 33.58 | 32.82 | 28.27 | 31.63 | 32.60 | 44.15 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 31.39 | 27.21 | 26.47 | 35.41 | 36.78 | 46.91 |
PS Ratio | 7.97 | 7.65 | 7.27 | 9.72 | 11.60 | 18.01 |
PB Ratio | 3.68 | 3.71 | 3.67 | 4.57 | 5.14 | 7.64 |
P/TBV Ratio | 4.39 | 4.47 | 3.85 | 4.72 | 5.36 | 8.02 |
P/FCF Ratio | 47.06 | 40.30 | 25.20 | 37.65 | 37.73 | 79.69 |
P/OCF Ratio | 23.29 | 22.75 | 16.68 | 31.37 | 30.27 | 37.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 7.19 | 6.73 | 6.22 | 8.55 | 10.34 | 16.71 |
EV/EBITDA Ratio | 20.22 | 17.49 | 17.03 | 24.58 | 29.00 | 42.78 |
EV/EBIT Ratio | 23.19 | 19.33 | 18.87 | 27.56 | 32.80 | 46.82 |
EV/FCF Ratio | 42.44 | 35.46 | 21.56 | 33.10 | 33.62 | 73.92 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.12 | 0.11 | 0.07 | 0.07 | 0.07 | 0.05 |
Debt / EBITDA Ratio | 0.71 | 0.58 | 0.38 | 0.40 | 0.44 | 0.27 |
Debt / FCF Ratio | 1.49 | 1.19 | 0.48 | 0.55 | 0.53 | 0.48 |
Net Debt / Equity Ratio | -0.37 | -0.41 | -0.52 | -0.57 | -0.57 | -0.60 |
Net Debt / EBITDA Ratio | -2.29 | -2.18 | -2.84 | -3.52 | -3.63 | -3.64 |
Net Debt / FCF Ratio | -4.71 | -4.42 | -3.59 | -4.74 | -4.21 | -6.29 |
Asset Turnover | 0.41 | 0.42 | 0.45 | 0.42 | 0.40 | 0.49 |
Inventory Turnover | 2.31 | 2.68 | 2.26 | 1.63 | 1.30 | 1.12 |
Quick Ratio | 3.83 | 3.82 | 4.13 | 4.84 | 4.11 | 5.40 |
Current Ratio | 4.31 | 4.22 | 4.45 | 5.35 | 4.61 | 6.11 |
Return on Equity (ROE) | 12.37% | 14.36% | 14.33% | 13.21% | 14.22% | 21.81% |
Return on Assets (ROA) | 7.90% | 9.23% | 9.32% | 8.11% | 7.80% | 10.96% |
Return on Invested Capital (ROIC) | 20.46% | 28.21% | 31.69% | 28.81% | 29.47% | 35.31% |
Return on Capital Employed (ROCE) | 13.00% | 15.20% | 16.20% | 14.30% | 13.70% | 14.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.22% | 3.67% | 3.78% | 2.82% | 2.72% | 2.13% |
FCF Yield | 2.13% | 2.48% | 3.97% | 2.66% | 2.65% | 1.26% |
Dividend Yield | 1.88% | 1.58% | 1.27% | 1.01% | 1.14% | 1.00% |
Payout Ratio | 48.61% | 33.21% | 48.30% | 42.15% | 48.75% | 37.55% |
Buyback Yield / Dilution | -1.09% | -0.58% | 0.12% | 0.23% | -11.81% | -19.10% |
Total Shareholder Return | 0.79% | 1.00% | 1.39% | 1.24% | -10.67% | -18.10% |